Outset Medical Long Term Debt 2019-2025 | OM
Outset Medical long term debt from 2019 to 2025. Long term debt can be defined as the sum of all long term debt fields.
| Outset Medical Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $197 |
| 2023 | $130 |
| 2022 | $96 |
| 2021 | $30 |
| 2020 | $30 |
| 2019 | $22 |
| 2018 | $0 |
| Outset Medical Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2025-03-31 | $94 |
| 2024-12-31 | $197 |
| 2024-09-30 | $197 |
| 2024-06-30 | $197 |
| 2024-03-31 | $197 |
| 2023-12-31 | $130 |
| 2023-09-30 | $97 |
| 2023-06-30 | $97 |
| 2023-03-31 | $96 |
| 2022-12-31 | $96 |
| 2022-09-30 | $30 |
| 2022-06-30 | $29 |
| 2022-03-31 | $30 |
| 2021-12-31 | $30 |
| 2021-09-30 | $30 |
| 2021-06-30 | $30 |
| 2021-03-31 | $30 |
| 2020-12-31 | $30 |
| 2020-09-30 | $30 |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.347B | $0.114B |
| Outset Medical Inc. is a medical technology company. Its Tablo(R) Hemodialysis System represents technological advancement enabling novel, transformational dialysis care in acute and home settings. Outset Medical Inc. is based in CA, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.989B | 58.51 |
| Hims & Hers Health (HIMS) | United States | $13.669B | 142.02 |
| Tempus AI (TEM) | United States | $11.962B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.646B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.825B | 59.77 |
| Hinge Health (HNGE) | United States | $3.100B | 0.00 |
| Privia Health (PRVA) | United States | $2.659B | 181.75 |
| Enovis (ENOV) | United States | $1.751B | 9.76 |
| Schrodinger (SDGR) | United States | $1.545B | 0.00 |
| Phreesia (PHR) | United States | $1.527B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.511B | 0.00 |
| Azenta (AZTA) | United States | $1.371B | 63.70 |
| 10x Genomics (TXG) | United States | $1.338B | 0.00 |
| Omnicell (OMCL) | United States | $1.324B | 23.36 |
| Claritev (CTEV) | United States | $0.663B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.618B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.534B | 0.00 |
| Veradigm (MDRX) | United States | $0.482B | 0.00 |
| Talkspace (TALK) | United States | $0.463B | 138.50 |
| Standard BioTools (LAB) | United States | $0.414B | 0.00 |
| TruBridge (TBRG) | United States | $0.346B | 766.67 |
| Nyxoah SA (NYXH) | Belgium | $0.263B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.150B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.139B | 0.00 |
| Pulmonx (LUNG) | United States | $0.111B | 0.00 |
| CareCloud (CCLD) | United States | $0.107B | 4.06 |
| American Well (AMWL) | United States | $0.106B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.096B | 0.00 |
| 111 (YI) | China | $0.068B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.046B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| Zhongchao (ZCMD) | China | $0.031B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |